graft-versus-host disease
Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate.
Donor <span class="gene" id="16518429-0-6-41">methylenetetrahydrofolate reductase</span> genotype is associated with <span class="disease" id="16518429-0-70-95">graft-versus-host disease</span> in hematopoietic stem cell transplant patients treated with methotrexate.